Neuropeptide FF analog RF9 is not an antagonist of NPFF receptor and decreases food intake in mice after its central and peripheral administration
暂无分享,去创建一个
[1] L. Lénárd,et al. Microinjection of RFRP-1 in the central nucleus of amygdala decreases food intake in the rat , 2012, Brain Research Bulletin.
[2] Rui Wang,et al. Neuropeptide FF and related peptides attenuates warm-, but not cold-water swim stress-induced analgesia in mice , 2012, Behavioural Brain Research.
[3] J. Meiler,et al. Selective mode of action of guanidine-containing non-peptides at human NPFF receptors. , 2012, Journal of medicinal chemistry.
[4] H. Meziane,et al. Involvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatments , 2012, British journal of pharmacology.
[5] A. Beck‐Sickinger,et al. RFamide Peptides: Structure, Function, Mechanisms and Pharmaceutical Potential , 2011, Pharmaceuticals.
[6] M. Řezáčová,et al. Characterization of prolactin-releasing peptide: Binding, signaling and hormone secretion in rodent pituitary cell lines endogenously expressing its receptor , 2011, Peptides.
[7] Rui Wang,et al. Neuropeptide FF receptor antagonist, RF9, attenuates the fever induced by central injection of LPS in mice , 2011, Peptides.
[8] L. Moulédous,et al. Opioid‐modulating properties of the neuropeptide FF system , 2010, BioFactors.
[9] L. Moulédous,et al. Opposite control of body temperature by NPFF1 and NPFF2 receptors in mice , 2010, Neuropeptides.
[10] D. Hesk,et al. 10th international symposium on the synthesis and applications of isotopes and isotopically labelled compounds—applications of isotopes in pharmaceutical research and development, Session 7, Tuesday, June 16, 2009 , 2010 .
[11] M. Tena-Sempere,et al. Characterization of the potent gonadotropin-releasing activity of RF9, a selective antagonist of RF-amide-related peptides and neuropeptide FF receptors: physiological and pharmacological implications. , 2010, Endocrinology.
[12] F. Bihel,et al. Pharmacological characterization of the mouse NPFF2 receptor , 2010, Peptides.
[13] C. Mollereau,et al. Characterization of two novel tritiated radioligands for labelling Neuropeptide FF (NPFF1 and NPFF2) receptors , 2009, Neurochemistry International.
[14] Rui Wang,et al. Neuropeptide FF receptors antagonist, RF9, attenuates opioid-evoked hypothermia in mice , 2008, Peptides.
[15] Rui Wang,et al. Inhibition of neuropeptide FF (NPFF)-induced hypothermia and anti-morphine analgesia by RF9, a new selective NPFF receptors antagonist , 2008, Regulatory Peptides.
[16] M. Iadarola,et al. Modulatory role of neuropeptide FF system in nociception and opiate analgesia , 2008, Neuropeptides.
[17] E. Šloncová,et al. Cocaine- and amphetamine-regulated transcript (CART) peptide specific binding in pheochromocytoma cells PC12. , 2007, European journal of pharmacology.
[18] M. Davisson,et al. Gonadotropes in a novel rat pituitary tumor cell line, RC-4B/C. Establishment and partial characterization of the cell line , 1990, In Vitro Cellular & Developmental Biology.
[19] M. Parmentier,et al. Correction for Simonin et al., RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia , 2006, Proceedings of the National Academy of Sciences.
[20] Justin,et al. RF 9 , a potent and selective neuropeptide FF receptor antagonist , prevents opioid-induced tolerance associated with hyperalgesia , 2006 .
[21] G. Dockray. The expanding family of ‐RFamide peptides and their effects on feeding behaviour , 2004, Experimental physiology.
[22] A. Puget,et al. Detailed distribution of neuropeptide FF receptors (NPFF1 and NPFF2) in the rat, mouse, octodon, rabbit, guinea pig, and marmoset monkey brains: A comparative autoradiographic study , 2004, Synapse.
[23] 東條 克能,et al. 正常ラット脳および下垂体における Cocaine-and amphetamine-regulated transcript(CART) peptide の免疫組織学的検討 , 2003 .
[24] P. Panula,et al. Prolactin Releasing Peptide Has High Affinity and Efficacy at Neuropeptide FF2 Receptors , 2003, Journal of Pharmacology and Experimental Therapeutics.
[25] Jilly F. Evans,et al. Identification and Characterization of Novel Mammalian Neuropeptide FF-like Peptides That Attenuate Morphine-induced Antinociception* , 2001, The Journal of Biological Chemistry.
[26] J. Zajac. Neuropeptide FF: new molecular insights. , 2001, Trends in pharmacological sciences.
[27] B. Borowsky,et al. Identification and Characterization of Two G Protein-coupled Receptors for Neuropeptide FF* , 2000, The Journal of Biological Chemistry.
[28] J. Zajac,et al. Neuropeptide FF Receptors of Mouse Olfactory Bulb: Binding Properties and Stimulation of Adenylate Cyclase Activity , 1997, Peptides.
[29] J. Zajac,et al. Hypothermic Effects of Neuropeptide FF Analogues in Mice , 1997, Pharmacology Biochemistry and Behavior.
[30] H. Arima,et al. Neuropeptide FF reduces food intake in rats , 1996, Peptides.
[31] J. Devillers,et al. Structure-activity study of neuropeptide FF: contribution of N-terminal regions to affinity and activity. , 1994, Journal of medicinal chemistry.
[32] B. Roth,et al. Elevation of arterial pressure in rats by two new vertebrate peptides FLF QPQRF-NH2 and AGE GLSSPFWSLAAPQRF-NH2 which are immunoreactive to FMRF-NH2 antiserum , 1987, Neuropeptides.
[33] A. Grossman,et al. THE OPIOID CONTROL OF LH AND FSH RELEASE: EFFECTS OF A MET‐ENKEPHALIN ANALOGUE AND NALOXONE , 1981, Clinical endocrinology.
[34] C. Chang,et al. Ribonucleotide reductase isolated from human cells. Heterogeneity among the sources. , 1978, Biochemical pharmacology.